Annals of Hematology

, Volume 89, Issue 10, pp 1069–1070

Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series

  • Rita Coutinho
  • Dolors Costa
  • Ana Carrió
  • Concha Muñoz
  • Ana Vidal
  • Mohammed Belkaid
  • Elias Campo
  • Benet Nomdedeu
Letter to the Editor

DOI: 10.1007/s00277-010-0932-2

Cite this article as:
Coutinho, R., Costa, D., Carrió, A. et al. Ann Hematol (2010) 89: 1069. doi:10.1007/s00277-010-0932-2
  • 101 Views

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Rita Coutinho
    • 1
  • Dolors Costa
    • 2
  • Ana Carrió
    • 2
  • Concha Muñoz
    • 2
  • Ana Vidal
    • 2
  • Mohammed Belkaid
    • 1
  • Elias Campo
    • 2
  • Benet Nomdedeu
    • 1
  1. 1.Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic IDIBAPSUniversity of BarcelonaBarcelonaSpain
  2. 2.Hematopathology Unit, Hospital Clinic IDIBAPSUniversity of BarcelonaBarcelonaSpain